The White House is proud to announce that President Biden will host the Global Fund's Seventh Replenishment Conference on September 19, 2022 in New York City. The United States is proud to be a founding contributor of, and the largest single donor to, the Global Fund, having contributed nearly $20 billion since 2002.
Founded in 2002, the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) is a unique financing mechanism that relies on a dynamic partnership among governments, the private sector, and civil society to fight HIV/AIDS, tuberculosis (TB), and malaria in ways that contribute to strengthening health systems.
Over the past 20 years, the Global Fund has invested more than $53 billion, saving 44 million lives and reducing the combined death rate from HIV, TB, and malaria by more than half in the low- and middle-income countries where the Global Fund invests.
The Global Fund rose to the challenge of the COVID-19 pandemic and mounted a rapid and innovative response to mitigate the impact of COVID-19 on HIV, TB and malaria programs, and to fill urgent response gaps in community health systems. Through its COVID-19 Response Mechanism (C19RM), the Global Fund is the primary channel for providing grants to low- and middle-income countries for COVID-19 tests, treatments (including medical oxygen and new therapeutics), personal protective equipment, and other critical elements for health systems to respond to COVID-19. In 2021, Congress provided $3.5 billion above regular appropriations for a U.S. contribution to the Global Fund for COVID-19-related needs, as part of the broader U.S. response to the pandemic.
The Global Fund's Seventh Replenishment Conference
The Global Fund's Seventh Replenishment Conference will bring together governments, civil society, and the private sector to take bold action toward the fight against HIV/AIDS, tuberculosis and malaria. The Global Fund's Seventh Replenishment investment case calls for at least $18 billion from donors to support low- and middle-income countries to get back on track to end HIV/AIDS, TB, and malaria as public health threats by 2030 given the devastating impact of COVID-19.
President Biden's FY 2023 budget includes a request for $2 billion for the Global Fund intended be a first part of a total U.S. $6 billion three-year Seventh Replenishment pledge, to save lives and continue the fight against HIV/AIDS, tuberculosis, and malaria.
The Global Fund raises funds ahead of each three-year grant cycle at replenishment conferences when donors formally pledge their intended contributions. The Seventh Replenishment Conference will raise funds to be used in the 2023-2025 grant cycle.
The Role of Government Donors
The United States encourages all government donors to support the Global Fund Replenishment and contribute robustly to the Seventh Replenishment in 2022. Global Fund grants reach over 120 low- and middle-income countries, and the Global Fund is the largest multilateral provider of grants for health systems. It is therefore critical, now more than ever, that we ensure it is fully replenished.
The United States looks to all donors to increase support to the Global Fund in order to reach the ambitious Replenishment target.
The Role of the Private Sector
The private sector is at the core of the Global Fund partnership, and it has been a key contributor ever since the Global Fund's creation. The Global Fund takes private sector innovations and rapidly scales them up to fast-track progress against HIV/AIDS, TB, and malaria in priority areas. Since 2002, private sector partners (including corporations, foundations, and philanthropists) have committed over $3.6 billion to the Global Fund. At the Sixth Replenishment Conference in 2019, the Global Fund's private sector partners committed a total of $1.13 billion.
The year 2022 represents an important inflection point: COVID-19 has brought global health to the fore for corporations, foundations, and philanthropists. The private sector, along with governments, civil society, and communities, will continue to be central to the Global Fund partnership. By contributing to the Seventh Replenishment, these stakeholders will support frontline health workers, improve disease surveillance capabilities, build stronger and more resilient supply chains, and increase innovations to reach those most in need and affected by HIV/AIDS, TB, and malaria. These activities will enhance global capacity to fight against these existing pandemics and contribute to efforts to prepare for future ones.
A Smart Investment That Saves Lives
A successful Global Fund Replenishment is projected to save 20 million lives between 2024 and 2026 and reduce the mortality rate by 64% across the three diseases by 2026, relative to 2020 levels. It would, through our collective efforts, avert more than 450 million infections between 2024 and 2026, reducing the incidence rate by 58% across the three diseases by 2026, relative to 2020 levels.
Global Fund Replenishment pledges will also catalyze a scale-up of domestic investments of up to $59 billion toward ending the three diseases and strengthening health systems through co-financing requirements and technical assistance on health financing.
A successful Global Fund Replenishment is expected to yield a return on investment of 1:31 - for every $1 invested in fighting the three diseases, there is $31 in health gains and economic returns, further contributing to the achievement of the overall United Nations Sustainable Development Agenda.
Through our shared commitment to the Global Fund, we will reduce inequities and inequalities in health services by addressing gender and human rights-related barriers to accessing health services and work with partners, including civil society and affected communities, to build more inclusive health systems that leave no one behind.
